Top 5 Pharmaceutical Companies of the Year 2025
Business Fortune
| Company | Management | Description |
| Dei BioPharma www.deibiopharma.com |
Dr. Matthias Magoola, Founder & Managing Director |
Dei BioPharma is redefining global healthcare with groundbreaking biotechnology, pioneering affordable life-saving drugs, vaccines, and revolutionary malaria treatments. Backed by a $1.1 billion world-class facility and 100+ US patents, it’s transforming lives across Africa and beyond through innovation, excellence, and global collaboration. |
| Cellares www.cellares.com |
Fabian Gerlinghaus, Co-Founder & CEO |
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is developing and operating integrated technologies to meet global demand for cell therapies. |
| HiFiBiO Therapeutics Inc. www.hifibio.com |
Liang Schweizer, Founder, Board Chair & CEO |
HiFiBiO Therapeutics Inc. is a clinical-stage biotech driving a pipeline of transformative immunotherapies. With its proprietary Drug Intelligence Science (DIS®) platform, the business is focusing on the underlying causes of illness. |
| Clinevo Technologies www.clinevotech.com |
Mani Vasudevan, CEO |
Clinevo Technologies is a Software Development Company specializing in tech solutions for Life Sciences R&D. They help Pharma, Biotech, and CROs reduce time and costs in clinical trials with innovations in data warehousing, analytics, automation, and AI. |
| Royalty Pharma www.royaltypharma.com |
Pablo Legorreta, Founder & CEO |
Royalty Pharma is the world’s largest buyer of biopharmaceutical royalties and a leading funder of innovation in life sciences. Its goal is to finance life sciences innovation by collaborating with biotech companies, pharmaceutical firms, and academic institutions to advance medication R&D. |
.webp)
